Vemurafenib inhibits immune escape biomarker BCL2A1 by targeting PI3K/AKT signaling pathway to suppress breast cancer

OBJECTIVES: To investigate the role of immune escape encoding genes on the prognosis of BC, and to predict the novel targeting agents. METHODS: Human immune genes and immune escape encoding genes were obtained from the IMMPORT database and the previous study. Sample information and clinical data on...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Yalan, Yang, Liqiong, Sakandar, Abass, Zhang, Duoli, Du, Fukuan, Zhang, Xinyi, Zou, Linglin, Zhao, Yueshui, Wang, Jigang, Zhang, Zhenhua, Wu, Xu, Li, Mingxing, Ling, Xiao, Yu, Lei, Dong, Lishu, Shen, Jing, Xiao, Zhangang, Wen, Qinglian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745811/
https://www.ncbi.nlm.nih.gov/pubmed/36524001
http://dx.doi.org/10.3389/fonc.2022.906197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745811/
https://www.ncbi.nlm.nih.gov/pubmed/36524001
http://dx.doi.org/10.3389/fonc.2022.906197

Ejemplares similares